KCEA-APO(a)-LRx Trial: Anti-sense Oligonucleotide Shows Promise in Reducing Blood Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease
A study led by Dr. Sotirios Tsimikas published in the New England…
Left Ventricular Myocardial Stiffness, an Early Sign of Stage B HFpEF, Is Observed in Patients With Left Ventricular Hypertrophy and Elevated Cardiac Biomarkers
A study led by Dr. Michinari Hieda published in Circulation showed that…
The Sarcomeric Human Cardiomyopathy Registry: Race Associated with Disease Expression and Clinical Outcomes Among Patients with Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited genetic disorder of the…
Persistently Elevated Neuropeptide Y, a Sympathetic Neurotransmitter, is Found to be Associated with Ventricular Arrhythmias in Patients with Myocardial Infarction
The sympathetic drive leading to the release of arrhythmogenic agents after myocardial…
385,000 Patient Study Shows Poor Sleep Behavior Associated With Increased Risk of Coronary Heart Disease and Stroke
A study led by Dr. Mengyu Fan published in the European Heart…
Patients with Out-Of-Hospital Cardiac Arrest Treated at Teaching Hospitals Are More Likely to Survive to 30 Days, Compared with Non-Teaching Hospitals
In a large population-based study, a significant and sustained survival benefit was…
Study Shows High-Intensity Statin Associated With Low Risk of Death, Stroke, ACS or Bleeding As Compared to Low to Moderate Intensity Statins or No Statins
Statins, especially high-intensity statins, could reduce the risk of a composite of…
Lower Levels of Circulating Progenitor Cells Associated with Increased Risk of Myocardial Infarction and Death In Patients with Stable Coronary Artery Disease
In patients with stable coronary artery disease, a decrease in circulating progenitor…
Study Suggests Coronary Microvascular Dysfunction and Not Glomerular Filtration Rate Associated with Abnormal Cardiac Mechanics and Worse Clinical Outcomes in Patients with Chronic Kidney Disease
A study led by Dr. Navakaranbir Bajaj published in Circulation showed that…
Three Million Patient Study Shows Patients With Cancer At Higher Risk of Dying from Cardiovascular Disease As Compared to the General Population
A study led by Dr. Kathleen Sturgeon published in the European Heart…
COMPLETE Trial OCT Substudy: Non-Culprit Lesions with Vulnerable Plaque Morphology Found In Half of Patients with STEMI and Multivessel Disease
The results of the COMPLETE Optical Coherence Tomography Substudy were presented by…
Interim Results of The EVAPORATE Trial Indicate No Change in Low Attenuation Plaque Volume But A Reduction in Total Plaque Volume Following Treatment with Icosapent Ethyl
The interim results of EVAPORATE trial, a study on the effect of…
ISCHEMIA CKD: No Difference In Outcomes Between Medical and Invasive Approaches to Ischemia in Patients with End Stage Renal Disease
The results of the International Study of Comparative Health Effectiveness with Medical…
GALILEO-4D: Rivaroxaban-Aspirin Based Anti-Thrombotic Therapy Post-TAVR Protects From Valve Leaflet Motion Abnormalities
An expanded analysis of 231 patients from the GALILEO trial comparing rivaroxaban-aspirin…
DAPA-HF: Dapagliflozin Improves Heart Failure Outcomes in Patients With HFrEF Regardless of Diabetic Status
Dr. John McMurray presented the results of the DAPA-HF trial at the…
BETonMACE: Trial Shows Novel BET Protein Inhibitor Apabetalone Is Safe and Could Potentially Be Used To Improve Cardiovascular Outcomes
During the American Heart Association 2019 meeting, Dr. Kosh Ray presented the…
Phase 1 Trial Shows RUC-4 (A Novel Subcutaneous GPIIb/IIIa Inhibitor) Achieves Safe, Rapid and Effective Platelet Inhibition
The results of a phase 1 trial that evaluated the safety of…
GALILEO: Rivaroxaban Based Anti-thrombotic Strategy Associated with Increased Risk of Death or Thromboembolic Events and Bleeding Compared to Antiplatelet Based Strategy in Patients with TAVR
The results of the GALILEO trial were presented by Dr. George Dangas…
ISCHEMIA: No Reduction in Cardiovascular Event in Patients with Stable Coronary Artery Disease Who Undergo Invasive Therapy
The results of the ISCHEMIA trial were presented by Dr. Judith Hochman…
COLCOT: Colchicine Reduced Cardiovascular Events in Patients with Recent Myocardial Infarction
The results of the COLCOT trial were presented by Dr. Jean-Claude Tardif…